EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profileg
EAU Edu Platform UROONCO

@EAU_Uroonco

The EAU Edu Platform for all healthcare professionals in uro-oncology. UROONCO is an initiative of the EAU in close collaboration with ESU and European Urology.

ID:2411218640

linkhttp://uroonco.uroweb.org calendar_today25-03-2014 15:57:28

1,5K Tweets

5,6K Followers

2,1K Following

EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

How do you navigate rectal complications in pelvic surgery? In this video interview with Dr. Giancarlo Marra, Dr. Pignot GΓ©raldine and Prof. Wiklund discuss key strategies & tips on preventing & managing rectal injuries during robotic-assisted πŸ‘‡

prostate.uroonco.uroweb.org/video/rectal-i…

account_circle
π™π™žπ™˜π™˜π™–π™§π™™π™€ π˜½π™šπ™§π™©π™€π™‘π™€ MD PhD(@RicBertolo) 's Twitter Profile Photo

Our comparative analysis focused on the perioperative and functional outcomes of single-layer vs. double-layer during partial nephrectomy is online!

➑️ pubmed.ncbi.nlm.nih.gov/38742552/

Visual abstract ⬇️

Our comparative analysis focused on the perioperative and functional outcomes of single-layer vs. double-layer #renorrhaphy #technique during #robotic partial nephrectomy is online! ➑️ pubmed.ncbi.nlm.nih.gov/38742552/ Visual abstract ⬇️
account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

Enfortumab vedotin in combination with pembrolizumab in the first-line setting demonstrated significant survival benefit as compared to chemotherapy in patients with metastatic bladder cancer.



uroweb.org/guidelines/mus…

account_circle
European School of Urology (EAU ESU)(@UrowebESU) 's Twitter Profile Photo

How do you deal with peculiar/challenging cases when performing ? Check out the 1st episode of the new series for tips & tricks from Profs. Paolo Gontero, Malavaud, Prof Param Mariappan, Joan Palou Redorta & Witjes.
Free registration + CME credit πŸ‘‡
webinars.uroweb.org/EAU/webinars/1…

How do you deal with peculiar/challenging cases when performing #TURBT? Check out the 1st episode of the new #UROwebinar series for tips & tricks from Profs. @paolo_gontero, Malavaud, @ParamMariappan, @joanfundi & Witjes. Free registration + CME credit πŸ‘‡ webinars.uroweb.org/EAU/webinars/1…
account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“Ή Novel intravesical chemotherapy delivery systems, TAR-200 & TAR-210, show impressive complete response rates in NMIBC patients. Learn more in this discussion between our BCa chief editor Dr. Benjamin Pradere & Assoc. Prof. FΓ©lix Guerrero-Ramos πŸ‘‡

bladder.uroonco.uroweb.org/video/novel-in…

account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“ΉWhat’s new in 2024 for oligometastatic ? Learn more in this discussion between our BCa associate editor Dr. Francesco Del Giudice and Prof. Alex Masson-Lecomte , including advanced imaging techniques & surgery vs. radiotherapy.
Watch the video here πŸ‘‡

bladder.uroonco.uroweb.org/video/oligomet…

account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“Ή Dr. Pawel Rajwa talks to Prof. tombal and Prof. Nick James about selecting optimal therapy for men with synchronous mHSPC. Discover the currently available treatments & know more about therapy objectives πŸ‘‡

prostate.uroonco.uroweb.org/video/manageme…

account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

πŸ†• Offer enzalutamide with or without ADT to M0 patients with high-risk BCR, defined as PSA-DT ≀9 mos and PSA level β‰₯2 ng/ml above nadir after RT or β‰₯1 ng/ml after radical prostatectomy with or without postoperative RT.



uroweb.org/guidelines/pro…

account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“ΉUROONCO PCa chief editor Dr. Giancarlo Marra talks to Prof. silke gillessen about the key takeaways of the EAU & APCCC session, which focused on mHSPC and PSA persistence after surgery, & the importance of collab among specialties. Watch it here πŸ‘‡

prostate.uroonco.uroweb.org/video/mhspc-an…

πŸ“ΉUROONCO PCa chief editor Dr. @GMarra_MD talks to Prof. @Silke_Gillessen about the key takeaways of the EAU & APCCC session, which focused on mHSPC and PSA persistence after surgery, & the importance of collab among specialties. Watch it here πŸ‘‡ prostate.uroonco.uroweb.org/video/mhspc-an…
account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“Ή Is bpMRI non-inferior to mpMRI in diagnosing ? Know more in this highly-informative discussion between UROONCO PCa associate editor Dr. Pawel Rajwa & Dr. Veeru Kasi on the PRIME trial πŸ‘‡

prostate.uroonco.uroweb.org/video/prime-st…

account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“ΉDon’t miss this high-informative conversation from , with our UROONCO RCC associate editor Dr. Kuusk interviewing Prof. Shankar Siva and Prof. Phillip Pierorazio on how to minimise overtreatment of small renal masses. πŸ‘‡

account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

The FASTRACK II clinical trial showed efficacy in . Despite an acceptable side-effect profile & renal function after SBRT, questions targeting various knowledge gaps could arise. Know more in the Article of the Month & Dr. Kuusk's commentary πŸ‘‡

kidney.uroonco.uroweb.org/publication/st…

account_circle
Stacy Loeb, MD(@LoebStacy) 's Twitter Profile Photo

RIP Digital rectal examination? ☠️ Nice summary by Declan Murphy of the limitations of DRE in the primary care setting and for early detection for urologists (in settings where high quality MRI is available)

RIP Digital rectal examination? ☠️ Nice summary by @declangmurphy of the limitations of DRE in the primary care setting and for early detection for urologists (in settings where high quality MRI is available) #APCCC24
account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“°EV-302 trial results show that EV+Pem is superior (ORR, PFS and OS) to chemotherapy in patients with previously untreated locally advanced or metastatic urothelial carcinoma. Learn more in the Article of the Month and commentary by Dr. Francesco Del Giudice πŸ‘‡

bladder.uroonco.uroweb.org/publication/en…

account_circle
Tom Powles(@tompowles1) 's Twitter Profile Photo

Just out in ESMO open ESMO - Eur. Oncology With 44.0 months of median follow-up nivolumab/cabozantinib continues to outperform sunitinib in M1 clear cell RCC. The 3 VEGF/TKI combinations have more similarities than differences and track each other with longer follow up gbr01.safelinks.protection.outlook.com/?url=https%3A%…

Just out in ESMO open @myESMO With 44.0 months of median follow-up nivolumab/cabozantinib continues to outperform sunitinib in M1 clear cell RCC. The 3 VEGF/TKI combinations have more similarities than differences and track each other with longer follow up gbr01.safelinks.protection.outlook.com/?url=https%3A%…
account_circle
European Association of Urology (EAU)(@Uroweb) 's Twitter Profile Photo

πŸ†• For high-risk localised or locally advanced prostate cancer, perform metastatic screening using PSMA-PET/CT if available and at least cross-sectional abdominopelvic imaging and a bone-scan.



uroweb.org/guidelines/pro…

account_circle
EAU Edu Platform UROONCO(@EAU_Uroonco) 's Twitter Profile Photo

πŸ“Ή What does the future hold for robotic surgery for ? Prof. Alex Mottrie talks to Dr. π™π™žπ™˜π™˜π™–π™§π™™π™€ π˜½π™šπ™§π™©π™€π™‘π™€ MD PhD about robotic , the emergence of single-port surgery, the latest in robotic platforms, telesurgery & more. πŸ‘‡

kidney.uroonco.uroweb.org/video/present-…

account_circle